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Abstract  Neuroblastoma  is  the  most  common,  non-central  nervous  system  tumor  of  childhood.
It has  the  potential  to  synthesize  catecholamines.  However,  the  presences  of  hypertension
are uncommon.  We  report  the  perioperative  management  of  a  15-month-old  infant  with  giant
abdominal  neuroblastoma  who  presented  severe  hypertension.  The  pathophysiological  alter-
ations of  neuroblastoma  are  reviewed  and  perioperative  management  presented.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Manejo  anestésico  de  crianc¸a com  neuroblastoma  abdominal  gigante
Resumo  Neuroblastoma  é  o  tumor  mais  comum  do  sistema  nervoso  não-central  na  infân-
cia. Esse  tumor  tem  o  potencial  para  sintetizar  catecolaminas;  entretanto,  a  presenc¸a  de
hipertensão  é  rara.  Relatamos  o  manejo  perioperatório  de  uma  crianc¸a  de  cinco  meses  de
idade com  neuroblastoma  abdominal  gigante  que  apresentou  hipertensão  grave.  As  alterac¸ões
ﬁsiopatológicas  do  neuroblastoma  foram  revistas  e  o  manejo  perioperatório  apresentado.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
aIntroductionPlease  cite  this  article  in  press  as:  Gómez-Ríos  MÁ,  et  al.  An
neuroblastoma.  Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/1
Neuroblastoma  is  the  most  common  extracranial  solid  tumor
in  childhood.1 It  affects  yearly  6--10  million  of  children,
∗ Corresponding author.
E-mail: magoris@hotmail.com (M.Á. Gómez-Ríos).
i
n
v
p
p
a
t
http://dx.doi.org/10.1016/j.bjane.2014.07.012
0104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Eccounting  7--8%  of  pediatric  tumors.  Clinical  presentation
s  highly  variable  depending  on  location.  It  may  include
onspeciﬁc  signs  and  symptoms  such  as  abdominal  pain,
omiting,  weight  loss,  anorexia,  fatigue,  diarrhea  and  pal-esthetic  management  of  an  infant  with  giant  abdominal
0.1016/j.bjane.2014.07.012
able  mass.2 Its  origin  is  embryonic,  developing  from
ostganglionic  sympathetic  nerve  ﬁbers,  and  it  can  be
ssociated  with  elevated  levels  of  catecholamine’s.  Never-
heless  hypertension  is  uncommon,  being  present  in  10--27%
lsevier Editora Ltda. All rights reserved.
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fFigure  1  Infant  after  anesthetic  induction.
f  cases.3 Possible  multiorganic  affectation,  mainly  effects
n  cardiovascular  and  respiratory  system,  as  well  as  the
reatment  of  severe  hypertension  deserve  to  be  reviewed.
he  parents  of  the  patient  gave  written  informed  consent
or  publication  of  this  article.
ase report
 15-month-old,  8.5  kg  boy  was  admitted  on  the  emer-
ency  department  of  our  institution,  with  fatigue,  partial
ejection  of  intake,  weight  loss,  vomiting  and  abdominal
istension  (Fig.  1).  Laboratory  testing  revealed  hyper-
ricemia  (7.1  mg/dL),  hypoalbuminemia  (3.2  g/dL),  LDH
205.0  IU/L,  sodium  129.0  mEq/L,  potassium  3.5  mEq/L,
hloride  90.0  mEq/L.  Abdominal  MRI  showed  a  large  abdom-
nal  mass  (12  cm  ×  10  cm  ×  10  cm)  encompassing  mesentery
nd  retroperitoneum  and  compressed  and  displaced  both
idneys,  surrounding  circumferentially  the  aorta  and  renal
rteries  and  veins  (Fig.  2).  Persistent  severe  hyperten-
ion  was  present  (180--120  mm/Hg).  Echocardiography  ruled
ut  the  presence  of  associated  heart  disease.  Intra-
enous  infusion  of  sodium  nitroprusside  (0.5--3  mg/kg/min)Please  cite  this  article  in  press  as:  Gómez-Ríos  MÁ,  et  al.  An
neuroblastoma.  Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/1
as  administered  for  acute  blood  pressure  control.  After
2  h,  sequential  oral  treatment  was  started  with  cloni-
ine  (20  mg/6  h),  nifedipine  (4  mg/6  h)  and  propranolol
3  mg/8  h),  reaching  a  stable  mean  arterial  pressure  target
Figure  2  Axial  MRI  shows  the  giant  intraabdominal  mass.
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f  100  mm/Hg.  A  MAP  lower  than  100  mm/Hg  determined
 critical  decrease  in  tissue  perfusion  pressure  reﬂected
ith  the  establishment  of  oligoanuria.  He  was  taken  to  the
perating  room  for  a  series  of  biopsies  (abdominal  mass,
one  marrow  and  lymph  nodes)  to  conﬁrm  the  diagno-
is.  Rapid  sequence  induction  was  performed  with  Sellick
aneuver  after  adequate  preoxygenation  with  100%  oxygen,
nd  anesthesia  induction  with  remifentanil  (0.2  g/kg/min),
ropofol  (2.5  mg/kg),  rocuronium  (1.2  mg/kg)  and  lido-
aine  (1  mg/kg).  Tracheal  intubation  produced  no  signiﬁcant
hanges  in  vital  signs.  The  pressure-controlled  ventilation
as  adjusted  to  maintain  normocapnia  using  a  mixture
f  oxygen-air  (FiO  50%).  Maintenance  of  general  anesthe-
ia  was  carried  out  using  sevoﬂurane  and  remifentanil
0.2--0.6  g/kg/min).  Persisted  hypertension  was  controlled
ith  established  antihypertensive  treatment  and  increasing
oses  of  remifentanil  during  the  surgery.  After  completion
f  the  surgical  procedure  infant  was  transferred  to  the
ICU  maintaining  intravenous  infusion  of  sodium  nitroprus-
ide.  The  diagnosis  of  neuroblastoma  was  conﬁrmed.  Urine
atecholamine’s  or  their  metabolites  were  undetectable.
he  subsequent  chemotherapy  and  tumor  resection  allowed
estoration  of  normal  blood  pressure.
iscussion
euroblastoma  derives  from  cells  of  neural  crest,  which
an  be  located  at  any  place  where  these  are  present  and
hey  retain  the  potential  to  synthesize  catecholamines.  Both
eatures  are  determinants  of  associated  pathophysiological
lterations.4
Its  location  is  usually  intraabdominal,  although  it  is  pos-
ible  intrathoracic  or  cervical  location  and  may  produce
irway  compromise.  The  presence  of  an  abdominal  mass
ncreases  intra-abdominal  pressure  (IAP).1 This  increases
he  risk  of  aspiration  therefore,  rapid  sequence  induction
s  recommendable.  In  the  respiratory  system  it  deter-
ines  cephalic  displacement  of  the  diaphragm,  increasing
ntrathoracic  pressure  and  decreasing  lung  compliance  and
unctional  residual  capacity,  which  determines  a  greater
endency  to  pulmonary  atelectasis,  impaired  ventilation
erfusion  ratio  after  induction  of  general  anesthesia  and
ypercapnia  and  hipoxemia.  It  produces  pulmonary  vasocon-
triction  and  increases  the  gas  exchange  impairment  in  the
lveolar-capillary  unit.  The  extent  of  changes  in  the  cardio-
ascular  system  is  dependent  on  the  magnitude  of  the  IAP,
resence  of  cardiomyopathy,  intravascular  volume  status,
ode  of  mechanical  ventilation,  surgical  conditions,  and
nesthetic  agents  employed.  Systemic  vascular  resistance
ncreases  due  to  mechanical  compression  of  the  abdominal
orta,  high  levels  of  neurohumoral  factors  like  vasopressin,
ctivation  of  the  renin--angiotensin--aldosterone  system  and
ompression  of  the  renal  arteries,  leading  to  hypertension.
his  high  afterload  increases  the  risk  of  acute  pulmonary
dema.  Compression  of  the  inferior  vena  cava  reduces
reload  and  cardiac  output  decreasing  tissue  perfusion,  par-
icularly  in  presence  of  hypovolemia.  Tachyarrhythmias  areesthetic  management  of  an  infant  with  giant  abdominal
0.1016/j.bjane.2014.07.012
requent  due  to  hypercapnia  and  increased  levels  of  circu-
ating  catecholamines.  All  these  changes  may  decrease  after
aparotomy  due  to  decompression  of  the  abdominal  cavity,
ut  the  correction  may  be  gradual.
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Table  1  Common  drugs  used  to  treat  hypertension  in  pediatric  patients.
Drug  Route  of
administration
Dose  Notes
Clonidine  PO  5--10  g/kg  24  h  (2--4  doses)  2-adrenergic  agonist.  Risk  of  prolonged  sedation.
Nifedipine  PO  0.25--0.5  mg/kg  4--6  h Dihydropyridine  calcium  antagonist.
Predominantly  vascular  effects.
Propranolol  PO/IV  0.05--0.2  mg/kg  iv
0.5--1  mg/kg  24  h  (3--4
doses)  vo
Nonselective    blockade.  Risk  of  bronchospasm,
myocardial  dysfunction,  AV  block  and
hypoglycemia.
Labetalol IV  0.25--1  mg/kg/h  Nonselective  blockade.  Side  effects  are  similar  to
those  of  propranolol.
Esmolol IV  50--200  g/kg/min  Relatively  selective  blockade.  Short  half-life
(10 min).
Sodium
nitroprusside
IV 0.5--10  g/kg/min  Potent  direct  relaxation  of  vascular  muscle  tissue,
both  arteriolar  and  venous  capacitance  vessels.
Potential  cyanide  toxicity;  reﬂex  tachycardia.
Nitroglycerin  IV  0.5--10  g/kg/min  Direct  smooth  muscle  relaxation,  predominantly
of venous  capacitance  vessels.
Phentolamine  IV  0.5--5  g/kg/min  Selective  blocker,  mainly  arteriolar  vasodilation.
Hydralazine IV  0.1--0.2  mg/kg  6  h  Direct  smooth  muscle  relaxation,  predominantly
of arteriolar.  Long  half-life.  Tachyphylaxis;  reﬂex
tachycardia;  thrombocytopenia;  lupus-like
syndrome.
Urapidil IV  Initially:  2  mg/kg/h
Maintenance:  0.8  mg/kg/h.
Max.  7  days
Elective  antagonist  of  peripheral  postsynaptic
1-adrenergic  receptors.
Enalapril PO/IV  0.1--0.5  mg/kg  24  h  (1--2
doses)  PO
5--10  g/kg  8--24  h  iv
Angiotensin  converting  enzyme  inhibitor.  Effect  of
long duration.  Hyperkalemia,  renal  failure,
angioedema;  severe  hypotension  with  anesthetic
agents.
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2PO, Orally; IV, intravenously.
Hypertension,  in  addition  to  the  above  mechanisms,
can  result  from  the  vasoconstrictor  action  of  cate-
cholamines  secreted  by  the  tumor  or  the  stimulation
of  the  renin--angiotensin--aldosterone  system  secondary
to  compression  of  the  renal  artery.  There  may  be
an  associated  cardiomyopathy  but  it  is  uncommon.  Its
etiology  is  multifactorial3;  it  includes  catecholamine-
induced  vasoconstriction,  coronary  vasospasm,  chronic
tachycardiomyopathy  secondary  to  a  hyperadrenergic  state,
b-adrenergic  receptors  down  regulation  and  promotion  of
calcium  inﬂux  into  sarcolema.  Effective  treatment  of  hyper-
tension  before  surgery  is  mandatory  to  reduce  perioperative
morbidity  and  mortality.  Intraoperative  hypertensive  crisis
may  occur,  especially  during  tracheal  intubation,  anesthetic
induction  and  tumor  manipulation.  Thus,  it  is  critical  to
minimize  the  sympathetic  response  secondary  to  direct
laryngoscopy.5 Thiopental,  succinylcholine,  and  morphine
should  be  used  with  caution  due  to  catecholamine  release
secondary  to  histamine  release  from  morphine  or  thiopental,
increased  abdominal  pressure  or  sympathetic  stimulation
following  succinylcholine.2 Intraoperative  hypertension  in
patients  with  catecholamine  secreting  neuroblastomas  is
controlled  using  short-acting  agents  such  as  sodium  nitro-Please  cite  this  article  in  press  as:  Gómez-Ríos  MÁ,  et  al.  An
neuroblastoma.  Rev  Bras  Anestesiol.  2014.  http://dx.doi.org/1
prusside,  calcium  antagonists,  phentolamine,  adenosine  or
prostaglandin  E1.2 The  use  of  antihypertensive  drugs  in  pedi-
atric  patients  should  be  initiated  in  the  lower  dose  under
close  cardiovascular  monitoring  and  titrated  to  effect.6,7
3able  1  shows  the  drugs  commonly  used  for  treating  hyper-
ension  in  pediatric  population.
Management  of  patients  with  giant  abdominal  neuro-
lastoma  is  an  anesthetic  challenge.  The  knowledge  of
athophysiological  implications  and  the  adequate  antihy-
ertensive  treatment  are  essential  for  successful  anesthetic
anagement.
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